Related Experiment Video
Updated: Feb 26, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
TRIM59 is a key regulator of growth and migration inrenal cell carcinoma
1Department of Clinical Laboratory, Affiliated Hospital of Dali University, Dali, China.
Abstract:
Renal cell carcinoma (RCC) is the most common renal neoplasms and metastatic is common. Previous data have shown that the tripartite motif (TRIM) family proteinswere implicated in human tumoriogenesis. In this study, we aimed to investigate the role of TRIM59 in the cell growth and migration in RCC. The expression of TRIM59 in human RCC tissues was initially examined by qRT-PCR. Alentivirus-based shRNA against TRIM59 (Lv-shTRIM59) was constructed. The effects of TRIM59 knockdown on cell proliferation were examined by in vitro MTT assay, colony formation assay and in vivo a mouse xenograft model of RCC. Cell migration and invasion after knockdown of TRIM59 were also examined by transwell assay. Our data showed that the mRNA level of TRIM59 in cancerous tissues was 2-fold increased as compared with non-cancerous tissues. Knockdown of TRIM59 in a RCC cell line 786-O significantly slowed down cell proliferative rate and decreased both the colony number and sizes. In the mouse model, knockdown of TRIM59 consistently inhibited tumor growth in vivo. Moreover, it was shown that cell migration and invasion were suppressed by 68% and 50%, respectively in TRIM59-depleted 786-O cells. Our data suggest that TRIM59 may serve as a pro-oncogenic protein in promoting the progression of RCC. Knockdown of TRIM59 may be a promising strategy concerning the early detection and treatment of RCC.
Insights
Tripartite motif 59 (TRIM59) promotes renal cell carcinoma (RCC) progression by enhancing cell growth and migration. Knocking down TRIM59 significantly inhibited tumor growth in vitro and in vivo, suggesting its potential as a therapeutic target for RCC.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Renal cell carcinoma (RCC) is a prevalent malignancy with a high metastatic rate.
- Tripartite motif (TRIM) family proteins are implicated in human tumorigenesis.
- The specific role of TRIM59 in RCC progression requires further investigation.
Purpose of the Study:
- To investigate the role of TRIM59 in the cell growth and migration of renal cell carcinoma.
- To evaluate the potential of TRIM59 as a therapeutic target for RCC.
Main Methods:
- Quantitative real-time PCR (qRT-PCR) to assess TRIM59 mRNA expression in RCC tissues.
- Lentivirus-based short hairpin RNA (shRNA) for TRIM59 knockdown in RCC cell lines.
- In vitro assays (MTT, colony formation, Transwell) and in vivo mouse xenograft models to evaluate proliferation, migration, and invasion.
Main Results:
- TRIM59 mRNA levels were significantly upregulated (2-fold) in cancerous RCC tissues compared to non-cancerous tissues.
- TRIM59 knockdown in 786-O cells reduced cell proliferation, colony formation, and tumor growth in vivo.
- TRIM59 depletion suppressed cell migration by 68% and invasion by 50% in 786-O cells.
Conclusions:
- TRIM59 acts as a pro-oncogenic protein, promoting the progression of renal cell carcinoma.
- Targeting TRIM59 through knockdown presents a promising strategy for the early detection and treatment of RCC.
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Negative Regulator Molecules
Mitogens and the Cell Cycle
Regulation of Angiogenesis and Blood Supply

